Pharmacogenetics: optimising prescribing in primary care

Essra Youssef; Tracey Thornley; David  Wright; Henk-Jan Guchelaar

doi:10.1002/psb.1982

Pharmacogenetics: optimising prescribing in primary care

Essra Youssef, Tracey Thornley, David Wright, Henk-Jan Guchelaar

Research output: Contribution to journal › Article › peer-review

11 Downloads (Pure)

Abstract

Pharmacogenetic (PGx) testing to personalise prescribing of certain medicines can improve patient outcomes and reduce adverse drug reactions. This article summarises the key findings of the PGx Impact study, designed to estimate the impact of pre-emptive genetic testing on prescribing, and discusses potential ways in which pharmacogenetic testing may optimise primary care prescribing in the near future.

Original language	English
Pages (from-to)	10-13
Number of pages	4
Journal	Prescriber
Volume	33
Issue number	5
DOIs	https://doi.org/10.1002/psb.1982
Publication status	Published - May 2022

Access to Document

10.1002/psb.1982

Accepted manuscriptAccepted author manuscript, 261 KB

https://doi.org/10.1002/psb.1982Licence: Unspecified

Cite this

@article{e65f10c881034948a2b9f124c82f4bae,

title = "Pharmacogenetics: optimising prescribing in primary care",

abstract = "Pharmacogenetic (PGx) testing to personalise prescribing of certain medicines can improve patient outcomes and reduce adverse drug reactions. This article summarises the key findings of the PGx Impact study, designed to estimate the impact of pre-emptive genetic testing on prescribing, and discusses potential ways in which pharmacogenetic testing may optimise primary care prescribing in the near future.",

author = "Essra Youssef and Tracey Thornley and David Wright and Henk-Jan Guchelaar",

year = "2022",

month = may,

doi = "10.1002/psb.1982",

language = "English",

volume = "33",

pages = "10--13",

journal = "Prescriber",

number = "5",

}

TY - JOUR

T1 - Pharmacogenetics: optimising prescribing in primary care

AU - Youssef, Essra

AU - Thornley, Tracey

AU - Wright, David

AU - Guchelaar, Henk-Jan

PY - 2022/5

Y1 - 2022/5

N2 - Pharmacogenetic (PGx) testing to personalise prescribing of certain medicines can improve patient outcomes and reduce adverse drug reactions. This article summarises the key findings of the PGx Impact study, designed to estimate the impact of pre-emptive genetic testing on prescribing, and discusses potential ways in which pharmacogenetic testing may optimise primary care prescribing in the near future.

AB - Pharmacogenetic (PGx) testing to personalise prescribing of certain medicines can improve patient outcomes and reduce adverse drug reactions. This article summarises the key findings of the PGx Impact study, designed to estimate the impact of pre-emptive genetic testing on prescribing, and discusses potential ways in which pharmacogenetic testing may optimise primary care prescribing in the near future.

U2 - 10.1002/psb.1982

DO - 10.1002/psb.1982

M3 - Article

VL - 33

SP - 10

EP - 13

JO - Prescriber

JF - Prescriber

IS - 5

ER -